A draft guideline has been issued by the CDE outlining the framework for sponsors to use real-world evidence (RWE) when seeking to expand pediatric drug indications, highlighting the necessity for early discussions with the regulator on RWE study plans.
This change affects data collection and presentation for pediatric label extensions, potentially influencing the efficiency and speed of bringing pediatric drugs to market in China.
Sponsors must implement early communication strategies with the CDE regarding RWE study plans as a prerequisite for pediatric indication extension submissions.
Regulatory Intelligence Lead
Review in the next regulatory intelligence cycle.
Provides technical considerations for using RWE data sources, study design, and data analysis to support pediatric label extensions. Emphasizes the need for early communication with CDE on RWE study plans.
Affects how sponsors collect and present real-world safety and efficacy data for pediatric indication extensions in China.
Sponsors must implement early communication strategies with the CDE regarding RWE study plans as a prerequisite for pediatric indication extension submissions.
The CDE draft guideline outlines a framework for using real-world evidence to support the extension of drug indications for pediatrics. It emphasizes the importance of early communication with the CDE and provides technical considerations for RWE data collection and analysis.
What changed: A draft guideline has been issued by the CDE outlining the framework for sponsors to use real-world evidence (RWE) when seeking to expand pediatric drug indications, highlighting the necessity for early discussions with the regulator on RWE study plans.
Why it matters: This change affects data collection and presentation for pediatric label extensions, potentially influencing the efficiency and speed of bringing pediatric drugs to market in China.
Practical implication: Sponsors must implement early communication strategies with the CDE regarding RWE study plans as a prerequisite for pediatric indication extension submissions.
Published from the Firecrawl policy change extraction pipeline.
Implement enhanced surveillance and tracking of Salmonella cases linked to imported eggs, potentially increasing ICSR submissions related to these infections.
Parents are encouraged to ensure their children receive timely vaccinations according to the NHS schedule to increase overall immunization rates and adherence to WHO guidelines.
Compounding pharmacies must verify that all components used in injectable drugs are suitable for their intended use and discontinue the use of any glutathione labeled for dietary supplement purposes, particularly if sourced from Medisca.
Update product labeling to include Lisraya as the first oral treatment for dermatomyositis, ensuring that all marketing and educational materials reflect its approval and associated safety information.
